Catalyst Wire Dossier Catalyst Wire Dossier

KTP 20%

· APR Applied Pharma Research s.a.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KTP 20%, covering 2020-02-18 to 2020-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study on the Onset of Action of KTP, 20% in the Treatment of Acute Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee [Phase 2]

See pricing